Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · IEX Real-Time Price · USD
4.780
-0.030 (-0.62%)
At close: May 31, 2024, 4:00 PM
4.660
-0.120 (-2.51%)
After-hours: May 31, 2024, 7:59 PM EDT
Ventyx Biosciences Market Cap
Ventyx Biosciences has a market cap or net worth of $336.99 million as of May 31, 2024. Its market cap has decreased by -84.14% in one year.
Market Cap
336.99M
Enterprise Value
44.92M
1-Year Change
-84.14%
Ranking
Category
Stock Price
$4.78
Market Cap Chart
Since the IPO on October 21, 2021, Ventyx Biosciences's market cap has decreased from $782.89M to $336.99M, a decrease of -56.96%. That is a compound annual growth rate of -27.62%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 30, 2024 | 339.10M | -2.45% |
May 29, 2024 | 347.60M | -3.90% |
May 28, 2024 | 361.70M | 17.40% |
May 24, 2024 | 308.10M | -1.79% |
May 23, 2024 | 313.70M | -4.82% |
May 22, 2024 | 329.60M | -1.38% |
May 21, 2024 | 334.20M | -1.85% |
May 20, 2024 | 340.50M | 2.10% |
May 17, 2024 | 333.50M | -5.01% |
May 16, 2024 | 351.10M | 18.86% |
May 15, 2024 | 295.40M | 0.48% |
May 14, 2024 | 294.00M | 1.20% |
May 13, 2024 | 290.50M | 0.76% |
May 10, 2024 | 288.30M | -8.71% |
May 9, 2024 | 315.80M | 20.03% |
May 8, 2024 | 263.10M | -3.59% |
May 7, 2024 | 272.90M | -2.22% |
May 6, 2024 | 279.10M | -2.89% |
May 3, 2024 | 287.40M | -1.20% |
May 2, 2024 | 290.90M | 4.90% |
May 1, 2024 | 277.30M | 25.14% |
Apr 30, 2024 | 221.60M | -2.46% |
Apr 29, 2024 | 227.20M | -2.45% |
Apr 26, 2024 | 232.90M | -3.20% |
Apr 25, 2024 | 240.60M | -4.22% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sutro Biopharma | 345.58M |
C4 Therapeutics | 344.03M |
Anavex Life Sciences | 343.64M |
Nevro | 343.41M |
Nautilus Biotechnology | 343.23M |
Zura Bio | 334.34M |
Xeris Biopharma Holdings | 334.32M |
Nanobiotix | 331.66M |